Not finding it? Sign in to also search OpenAlex live.
-
Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early‐Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized‐Controlled Trials2026 Clinical and Translational Science article Health Professions Clinical Laboratory Practices and Quality Control Open access
Jannik Rousel, Tessa Niemeyer‐van der Kolk, Matthijs Moerland, Robert Rißmann, Naomi B. Klarenbeek, Maurits F. J. M. Vissers, +1 more
0citations -
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
Philippe Gabríel Steg, Michael J. Szarek, J. Wouter Jukema, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, +81 more
29citations -
OP0261 THE NATURAL SEQUENCE IN WHICH SUBCLINICALLY INFLAMED JOINT TISSUES PROGRESS TO CLINICAL ARTHRITIS OR SUBSIDE; A STUDY ON SERIAL MRIS IN THE PLACEBO-ARM OF THE TREAT EARLIER TRIAL2023 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Doortje I Krijbolder, X. Matthijssen, Quirine A Dumoulin, B. Van Dijk, Hanna W. van Steenbergen, Debbie M. Boeters, +3 more
0citations -
Modulating Placebo Effects in Clinical Trials: Study Team Briefing to Optimize Drug–Placebo Differences2025 Clinical and Translational Science article Neuroscience Pain Management and Placebo Effect Open access
Martin Coenen, Ulrike Bingel, Maria Soledad Berdaguer, Christine Fuhrmann, Robert Németh, Jens Rengelshausen, +3 more
0citations -
Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis2023 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Naveen Pemmaraju, Adam J. Mead, Tim C. P. Somervaille, James K. McCloskey, Francesca Palandri, Steffen Koschmieder, +18 more
42citations -
De BUSCOPAN-studie. Een gerandomiseerde non-inferioriteitsstudie van continue butylscopolamine-infusie versus placebo voor niersteenkoliek onvoldoende reagerend op non-steroïdale anti-inflammatoire medicatie2022 Tijdschrift voor Urologie article Medicine Kidney Stones and Urolithiasis Treatments Open access
Saskia Weltings, K. Tim Buddingh, Daniëlle C. van Diepen, Rob C.M. Pelger, Hein Putter, Mandana Rad, +2 more
0citations -
Type-2 Inflammation and Lung Function Changes in the Placebo Arms of Asthma Clinical Trials: Findings from the ORACLE2 Meta-analysis2025 American Journal of Respiratory and Critical Care Medicine conference-abstract Medicine Asthma and respiratory diseases
Samuel Mailhot-Larouche, Fleur L. Meulmeester, Carlos Andrés Celis-Preciado, Samuel Lemaire‐Paquette, Sanjay Ramakrishnan, M.E. Wechsler, +19 more
1citations -
Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial)
Britta Hoechsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Joerg Westermann, Beatrice Drexler, +10 more
0citations -
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN2023 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Richard A. Lafayette, Bart Maes, Celia J. F. Lin, Sean J. Barbour, Richard K. S. Phoon, Sung Gyun Kim, +4 more
14citations -
Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation.2025 Journal of Clinical Oncology article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Alexander C. J. van Akkooi, Mario Mandalà, Michal Kiciński, Anne-Sophie Govaerts, Axel Hauschild, Piotr Lukasz Rutkowski, +14 more
0citations -
Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups
Sonia Jaramillo Segura, Maxi Wass, Judith Schaffrath, Kathrin Rieger, Axel Nogai, Mathias Haenel, +46 more
5citations -
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, Walter de Millas, Peter Falkai, Wolfgang Gäebel, +18 more
22citations -
LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study2021 Open Forum Infectious Diseases conference-abstract Medicine Respiratory viral infections research Open access
Ann Regina Falsey, Kristi L. Williams, Efi Gymnopoulou, Stephan Bart, John E. Ervin, Arangassery Rosemary Bastian, +9 more
14citations -
Patient-Reported Outcomes: Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis2023 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Caroline Irene Piatek, Jong Wook Lee, Morag Griffin, Jun‐ichi Nishimura, Christopher Jordan Patriquin, Hubert Schrezenmeier, +9 more
0citations -
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial
Stewart J. Tepper, Henrik Winther Schytz, R O B V Jensen, Christofer Lundqvist, Gisela Marie Terwindt, Cristina Tassorelli, +8 more
1citations -
Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma
Emanuel Bührer, Nina Glassée, Michal Kiciński, Oliver John Kennedy, Christian U. Blank, Georgina Venetia Long, +26 more
0citations -
Results of a randomized, double-blind, placebo-controlled, phase 2 study (OpcemISA) of the combination of ISA101b and cemiplimab versus cemiplimab for recurrent/metastatic (R/M) HPV16-positive oropharyngeal cancer (OPC).2024 Journal of Clinical Oncology conference-abstract Medicine Head and Neck Cancer Studies Open access
Caroline Even, Kevin Joseph Harrington, Erminia Massarelli, Marielle Klein Hesselink, Sonja Visscher, Matthew G. Fury, +13 more
18citations -
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent
Jürgen Floege, Richard A. Lafayette, Jonathan Barratt, Brian S. Schwartz, Paul T. Manser, Uptal D. Patel, +7 more
39citations